T5601640 , 98% , 924473-59-6

Synonym(s):
3-Methyl-N-[3-[[[3-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-5-isoxazolecarboxamide;T5601640

CAS NO.：924473-59-6

Empirical Formula: C19H14F3N3O3

Molecular Weight: 389.33

MDL number:

EINECS: 604-604-1

PRODUCT Properties

• Boiling point: 403.4±45.0 °C(Predicted)
• Density: 1.426±0.06 g/cm3(Predicted)
• storage temp.: 2-8°C
• solubility: DMF: 30 mg/ml; DMF:PBS(pH7.2) (1:2): 0.33 mg/ml; DMSO: 20 mg/ml
• form: powder
• pka: 11.41±0.70(Predicted)
• color: white to beige
• InChI: 1S/C19H14F3N3O3/c1-11-8-16(28-25-11)18(27)24-14-6-2-4-12(9-14)17(26)23-15-7-3-5-13(10-15)19(20,21)22/h2-10H,1H3,(H,23,26)(H,24,27)
• InChIKey: XVOKFRPKSAWELK-UHFFFAOYSA-N
• SMILES: O=C(NC1=CC(C(F)(F)F)=CC=C1)C2=CC(NC(C3=CC(C)=NO3)=O)=CC=C2

Description and Uses

T 5601640 is a LIMK inhibitor and is used for the treatment of proliferative disorders such as cancer, neurofibromatosis and neuronal differentiation associated disaeses.

Safety

• Symbol(GHS): GHS06
• Signal word: Danger
• Hazard statements: H301-H413
• Precautionary statements: P273-P301+P310+P330
• RIDADR: UN 2811 6.1 / PGIII
• WGK Germany: WGK 3
• Storage Class: 6.1C - Combustible acute toxic Cat.3; toxic compounds or compounds which causing chronic effects
• Hazard Classifications: Acute Tox. 3 Oral; Aquatic Chronic 4